ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AUTL Autolus Therapeutics PLC

4.53
-0.03 (-0.66%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Autolus Therapeutics PLC AUTL NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.03 -0.66% 4.53 08:01:36
Open Price Low Price High Price Close Price Previous Close
4.58 4.49 4.71 4.48 4.56
more quote information »

Recent News

Date Time Source Heading
23/4/202421:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02/4/202422:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01/4/202422:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14/3/202422:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12/3/202422:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11/3/202422:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29/2/202423:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
24/2/202409:28EDGAR2Form D - Notice of Exempt Offering of Securities
22/2/202423:00GLOBEAutolus Therapeutics announces publication in Nature..
22/2/202409:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/2/202400:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202409:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/2/202408:17EDGAR2Form 8-K - Current report
08/2/202423:00GLOBEAutolus Announces Pricing of Underwritten Offering
08/2/202422:06EDGAR2Form 8-K - Current report
08/2/202421:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
08/2/202414:00EDGAR2Form S-3ASR - Automatic shelf registration statement of..
01/2/202408:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/1/202405:02EDGAR2Form 8-K - Current report
23/1/202423:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
22/1/202423:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
22/1/202423:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
11/1/202407:12EDGAR2Form 8-K - Current report
10/1/202423:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
23/12/202300:24EDGAR2Form 8-K - Current report
22/12/202323:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
12/12/202300:31EDGAR2Form 8-K - Current report
10/12/202312:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
29/11/202306:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202323:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
27/11/202323:07EDGAR2Form 8-K - Current report
27/11/202323:00GLOBEAutolus Therapeutics Submits Biologics License Application..
15/11/202323:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
10/11/202308:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202301:18EDGAR2Form 8-K - Current report
06/11/202323:00GLOBEAutolus Therapeutics announces participation in upcoming..
04/11/202307:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/11/202307:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202300:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
02/11/202322:11GLOBEAutolus Therapeutics Reports Third Quarter 2023 Financial..
17/10/202322:00GLOBEAutolus Therapeutics to host virtual event to discuss the..
11/10/202323:07GLOBECorrection - Autolus Therapeutics to report third quarter..
11/10/202322:00GLOBEAutolus Therapeutics to report third quarter 2023 financial..
05/9/202321:00GLOBEAutolus Therapeutics announces data from AUTO1/22 trial in..
08/8/202306:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/8/202306:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202321:00GLOBEAutolus Therapeutics Reports Second Quarter 2023 Financial..
22/7/202306:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/7/202321:00GLOBEAutolus Therapeutics to report second quarter 2023 financial..
11/7/202307:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..

Your Recent History

Delayed Upgrade Clock